Insulin resistance increases starting in midlife due to decreasing estrogen production and other aging-related factors. Higher intensity physical activity (PA) has the potential to attenuate rising insulin resistance; however, longitudinal associations of PA and insulin resistance have not been studied in midlife women. We used data from the Study of Women’s Health Across the Nation (SWAN, N=3,230), a cohort study with up to 17 years of follow-up, to estimate longitudinal associations of higher intensity PA with insulin resistance. Women reported PA using the Kaiser Physical Activity Survey at 7 study visits (V0, V3, V5, V6, V9, V12, V13). We used the sports and exercise physical activity index score (range: 1-5) to assess leisure-time moderate to vigorous intensity PA (MVPA). SWAN measured glucose and insulin in blood collected at 8 study visits (V0, V1, V3-V7, V12, V13). We used generalized estimating equations to estimate the adjusted longitudinal associations of MVPA with homeostatic model assessment of insulin resistance (HOMA-IR) overall, by baseline body mass index (BMI) category, and by race/ethnicity. Women were 46 (SD=3) years old at baseline. Forty-seven percent were non-Hispanic white; 28% black; 9% Japanese; 8% Chinese, and 8% Hispanic. Each additional one-unit increase in reported MVPA was associated with an average 0.2 unit lower HOMA-IR (95% CI: -0.3, -0.1) over time. Associations differed by baseline BMI (interaction P<0.001). Reported MVPA was associated with a 0.1 lower HOMA-IR (95% CI: -0.1, -0.02) in normal weight women, a 0.2 lower HOMA-IR (95% CI: -0.3, -0.1) in overweight women, and a 0.4 lower HOMA-IR (95% CI: -0.6, -0.1) in obese women. MVPA was not associated with HOMA-IR in underweight women (mean difference=0.0; 95% CI: -0.1, 0.1). Associations did not differ by race/ethnicity (interaction P=0.39). Our findings support longitudinal associations of MVPA with lower insulin resistance in midlife women, with the strongest associations in obese women.

Disclosure

S.E. Badon: None. K. Pettee Gabriel: None. C.A. Karvonen-Gutierrez: None. B. Sternfeld: None. J. Lee: None. E. Gold: None. E. Waetjen: None. M. Hedderson: None.

Funding

National Institutes of Health; U.S. Department of Health and Human Services; National Institute on Aging; National Institute of Nursing Research; Office of Research on Women’s Health (U01NR004061, U01AG012505, U01AG012535, U01AG012531, U01AG012539, U01AG012546, U01AG012553, U01AG012554, U01AG012495); National Center for Research Resources; National Center for Advancing Translational Sciences (UCSF-CTSI UL1RR024131)

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.